< Back to previous page
Main organisation:VIB-UGent Center for Medical Biotechnology
Lifecycle:1 Jan 2017 → Today
Organisation profile:Developing innovative molecular technology to enable novel approaches to study, diagnose and treat immune-system related disease, focus on microbial cell engineering as a basis for the discovery and development of novel immunomodulatory, developing new glyco-analysis tools and animal models to pursue the role of inflammation-induced lymphocyte glycosylation changes in the pathophysiology of inflammatory disease biopharmaceuticals.
Keywords:Biochemistry, Proteins, Virology, Vaccines, Molecular diagostics, hepatology
Disciplines:Biochemistry and metabolism, Molecular and cell biology, Bioinformatics and computational biology, Diagnostics